JANUMET (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the JANUMET drug offered from Merck Sharp & Dohme Corp.. This Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | SITAGLIPTIN and METFORMIN HYDROCHLORIDE |
| SUBSTANCE NAME: | SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-03-30 |
| END MARKETING DATE: | 0000-00-00 |
JANUMET HUMAN PRESCRIPTION DRUG Details:
| Item Description | JANUMET from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 500(mg/1; mg/1) |
| START MARKETING DATE: | 2007-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0575_1702daca-0ba2-476b-a9a3-0b977320b868 |
| PRODUCT NDC: | 0006-0575 |
| APPLICATION NUMBER: | NDA022044 |
Other SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
